7th Annual SiNERGe Sickle Cell Symposium

Sickle Cell Disease is the most common of the rare diseases. Despite over 100,000 individuals living with sickle cell disease, there is a lack of providers knowledgeable in the management of sickle cell disease. This barrier to accessing quality evidence-based care leads to poor outcomes and poor utilization.

This course aims to address the paucity of sickle cell knowledge among healthcare providers and team members who provide care for patients with sickle cell disease by providing information and development activities to promote quality improvement in sickle cell disease care. Annual Report Description: Sickle Cell Disease is the most common of the rare diseases.

Despite over 100,000 individuals living with sickle cell disease, there is a lack of providers knowledgeable in the management of sickle cell disease. This barrier to accessing quality evidence-based care leads to poor outcomes and poor utilization. This course aims to address the paucity of sickle cell knowledge among healthcare providers and team members who provide care for patients with sickle cell disease by providing information and development activities to promote quality improvement in sickle cell disease care.

Successful Completion
To successfully complete this activity, the required evaluation must be completed no later than Sunday, October 19, 2025. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

1. Manage individuals with illness related to sickle cell disease.
2. Distinguish best practices and national guidelines for the care of an individual with sickle cell disease.
3. Appraise opportunities for quality improvement in sickle cell care in health care organizations.
4. Apply strategies for recruiting sickle cell care providers to telemonitoring opportunities.
5. Summarize a Plan - Do - Act Cycle for quality improvement projects.

Registration for this activity is closed. Any questions should be directed to [email protected].

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 12.00 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 12.00 nursing contact hours.

Physicians Assistants:

 Thomas Jefferson University has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 12.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Other Healthcare Professionals: This educational activity is designated for 12.00 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

ABIM

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ABP

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 12.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Agenda
Agenda subject to change without notice.

 Jefferson Release Policy
Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy
As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Photography and Recording
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be asked to vacate the activity. No credits or refund will be issued.

Copyright
All rights reserved – Thomas Jefferson University. No part of this program may be used, reproduced, or shared in any manner whatsoever without express written permission, except in the case of brief quotations embodied in articles or reviews.

Jefferson Alumni Hall
1020 Locust Street
Philadelphia, PA 19107

Directions

Parking

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Vinal Menon, PhD
Research Associate
Johns Hopkins University
Baltimore, MD

Co-Director

Nothing to disclose

Ashley Lauriello, MSN
Program Manager-Division of Hematology
Thomas Jefferson University Hospital
Philadelphia, PA

Co-Director, Faculty, Nurse Planner

Consulting Fee-QUILT Health

C. Patrick Carroll, MD
Director of Psychiatric Services, Sickle Cell Center for Adults
John Hopkins University
Baltimore, MD

Faculty

Gregory C Kane, MD, MACP
Jane and Leonard Korman Professor of Pulmonary Medicine; Chair, Department of Medicine
Thomas Jefferson University
Philadelphia, PA

Faculty

Nothing to disclose

Elizabeth S Klings, MD, Professor of Medicine
Director of Clinical Research, Center of Excellence in Sickle Cell Disease
Boston Univ Sch of Med
Jamaica Plain, MD

Faculty

Consulting Fee-Novo Nordisk (Any division)|Advisor-Pfizer (Any division)|Grant or research support-Novartis Corporation Pharmaceuticals|Grant or research support-Pfizer (Any division)

Lydia H Pecker, MD
Director, Young Adult Clinic, Johns Hopkins Sickle Cell Center for Adults
John Hopkins University
Baltimore, MD

Faculty

Kenneth Rivlin, MD, PhD
Director of the Division of Pediatric Hematology and Oncology
Albert Einstein College of Medicine at Yeshiva University
Bronx, NY

Faculty

Amy E Sobota, MD, MPH
Chief of Pediatric Hematology/Oncology
Boston Medical Center
Boston, MA

Faculty

Rosalyn Stewart, MD, MS, MBA
Professor
John Hopkins University
Baltimore, MD

Faculty

Sophie Lanzkron, MD, MHS
Director, Division of Hematology
Thomas Jefferson University
Philadelphia, PA

Faculty, Physician Planner

Consulting Fee-Bluebird bio|Consulting Fee-Novo Nordisk (Any division)|Consulting Fee-Merck (Any division) (Relationship has ended)|Consulting Fee-Pfizer (Any division)|Consulting Fee-Novartis Corporation Pharmaceuticals (Relationship has ended)|Grant or research support-CSL Behring, LLC (Relationship has ended)|Grant or research support-Novartis Corporation Pharmaceuticals (Relationship has ended)|Grant or research support-Takeda Pharmaceuticals (Any division) (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Pfizer (Any division)|Stocks or stock options, excluding diversified mutual funds-Teva Pharmaceutical Industries|Consulting Fee-Beam Therapeutics|Consulting Fee-Agios (Relationship has ended)

Meemansa Menon, MCom
Research Program Coordinator
Johns Hopkins University
Baltimore, MD

Other Planning Committee Member

Nothing to disclose

Sharon O Sorungbe, MPH, CPH
Sr. Research Program Coordinator
Johns Hopkins University
Baltimore, MD

Other Planning Committee Member

Nothing to disclose